Publicaciones en colaboración con investigadores/as de Charles University in Prague (13)

2023

  1. Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry

    The European respiratory journal

  2. Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry (Respiratory Research, (2022), 23, 1, (352), 10.1186/s12931-022-02275-4)

    Respiratory Research

2022

  1. Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry

    Respiratory Research, Vol. 23, Núm. 1

2019

  1. Comparative genomics of the major parasitic worms

    Nature Genetics, Vol. 51, Núm. 1, pp. 163-174

2017

  1. Cardiovascular efficacy and safety of bococizumab in high-risk patients

    New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539

2016

  1. The European guideline on management of major bleeding and coagulopathy following trauma: Fourth edition

    Critical Care, Vol. 20, Núm. 1

2013

  1. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 15, Núm. 10, pp. 1173-1184

2010

  1. Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia

    International Journal of Clinical Practice, Vol. 64, Núm. 6, pp. 727-738

2008

  1. Glycogen phosphorylase in Acanthamoeba spp.: Determining the role of the enzyme during the encystment process using RNA interference

    Eukaryotic Cell, Vol. 7, Núm. 3, pp. 509-517

2007

  1. Erratum: Management of bleeding following major trauma: A European guideline (Critical Care (2007))

    Critical Care

  2. Management of bleeding following major trauma: A European guideline

    Critical Care, Vol. 11

2004

  1. Continuing outcomes relevant to Evista: Breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene

    Journal of the National Cancer Institute, Vol. 96, Núm. 23, pp. 1751-1761

1999

  1. Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: Results of the FOSIT study

    Osteoporosis International, Vol. 9, Núm. 5, pp. 461-468